TCR2 Therapeutics Inc.
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
Last updated:
Abstract:
Provided herein are T-cell receptor (TCR) fusion proteins (TFPs), T-cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.
Status:
Application
Type:
Utility
Filling date:
2 Aug 2017
Issue date:
22 Aug 2019